Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | VENUSREM Venus Remedies Limited Pharma · Small | KPL Kwality Pharmaceuticals Limited Pharma · Small | VIMTALABS Vimta Labs Limited Pharma · Small | MOREPENLAB Morepen Laboratories Limited Pharma · Small |
|---|---|---|---|---|
| Final Score | 60 | 55 | 46 | 27 |
| Verdict | UNDERVALUED | FAIR VALUE | FAIR VALUE | OVERVALUED |
| Style | Growth at Value | Premium Compounder | Financial Turnaround | OVERVALUED |
| Piotroski | 7/9 | 8/9 | 8/9 | 7/9 |
| Valuation | 13/30 | 4/30 | 3/30 | 5/30 |
| Growth | 18/25 | 18/25 | 17/25 | 4/25 |
| Quality | 13/20 | 16/20 | 8/20 | 0/20 |
| Balance Sheet | 8/15 | 9/15 | 9/15 | 9/15 |
| Cash Flow | 4/10 | 4/10 | 4/10 | 4/10 |
| Price | ₹1,610.7 | ₹2,338.6 | ₹527.85 | ₹48.65 |
| P/E | 22.00 | 34.70 | 38.70 | 31.60 |
| P/B | 3.41 | 7.10 | 6.83 | 1.88 |
| ROE | 16.80% | 22.80% | 13.50% | 6.20% |
| ROCE | 21.70% | 24.20% | 17.60% | 8.05% |
| Debt / Equity | 0.02 | 0.39 | 0.04 | 0.17 |
| FCF Yield | — | — | — | — |
| Dividend Y | — | — | 0.38% | 0.47% |
| Altman Z | 8.81 | 7.88 | 8.95 | 5.05 |
| Promoter % | 41.76% | 54.87% | 35.85% | 35.66% |
| Mkt Cap (₹Cr) | 2266.00 | 2356.00 | 2354.00 | 2349.00 |
| Graham # | ₹927.33 | ₹683.63 | ₹155.05 | ₹29.79 |
| Fair PE | 42.0 | 42.0 | 42.0 | 5.4 |
| MoS % | +50.1% | +14.2% | +9.2% | -420.7% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startVENUSREM508
KPL144
VIMTALABS76
MOREPENLAB58